COVID-19 Booster Readiness Survey

Geisinger Health

Status: Completed

Conditions: Vaccination Refusal

Treatments: Behavioral: Salience of Omicron variant; Behavioral: Self-protection message; Behavioral: Other-protection message

Study type: Interventional

Funder types: Other

Identifiers

NCT05529030

2022-0726

Details and patient eligibility

About

The purpose of this administrative survey is to inform health system logistics by assessing the attitudes towards towards the bivalent COVID-19 boosters held by healthcare workers (HCWs) at a large, rural health system. It will also test, prospectively, the effect on interest in the bivalent COVID-19 booster of different framing approaches in a survey question sent to employees of a large, rural health system.

Full description

The Food and Drug Administration has authorized two bivalent COVID-19 boosters with the expectation that the Centers for Disease Control will soon recommend them. The researchers plan to survey the HCWs at a large, rural health system on their attitudes on the bivalent booster.

This survey will gather data on HCWs' interest in a bivalent booster, reasons for hesitancy, risk perception about COVID-19 infection and its complications, and prior COVID-19 infection and vaccination.

Respondents will also be randomly assigned to see different versions of the question asking if they are interested in a bivalent booster with different framing approaches, such as protection of the self or protection of patients (for patient-facing employees). Information on prior vaccination and perceptions of risk will also be gathered and used as covariates in the analysis.

Enrollment: 12,036 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Employee at the health system

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

12,036 participants in 4 patient groups

Standard question

No Intervention group

Description:

Question with no additional text or framing

Question with salient Omicron message

Experimental group

Description:

Question indicates that the bivalent booster can protect the respondent from the Omicron variant

Treatment:

Behavioral: Self-protection message

Behavioral: Salience of Omicron variant

Question with patient protection message

Experimental group

Description:

Question indicates that the bivalent booster can protect patients (only presented to patient-facing employees)

Treatment:

Behavioral: Other-protection message

Question with salient Omicron and patient protection message

Experimental group

Description:

Question indicates that the bivalent booster can protect patients from the Omicron variant (only presented to patient-facing employees)

Treatment:

Behavioral: Salience of Omicron variant